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Hyaluronan Accumulation  
in Wounded Epidermis:  
A Mediator of Keratinocyte Activation
Raija H. Tammi1 and Markku I. Tammi1
The high-molecular-mass polysaccharide hyaluronan is abundant in the extracel-
lular space between adjacent keratinocytes throughout the vital part of epidermis. 
It has a rapid turnover, and its content is subject to large fluctuations due to physio-
logical and environmental conditions, with the strongest effects mediated by EGFR 
signaling. Using an elegant organotypic culture system, Monslow et al. (2009, this 
issue) demonstrate that heparin-binding (HB)-EGF released from its membrane 
anchor is the major ligand of EGFR in injured epidermis, accounting for the auto-
crine and paracrine activation of hyaluronan synthesis by the keratinocytes in the 
neighborhood, thus facilitating the epidermal wound-healing response.
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organ cultures and organotypic cultures 
in epidermal research
Isolated keratinocytes in monolayer cul-
tures lack many of the regulatory pro-
cesses operating in the epidermis, where 
stratified keratinocytes exist at different 
stages of differentiation. One example 
is heparin-binding (HB)-EGF, which is 
expressed and secreted by differentiat-
ing keratinocytes but targets proliferating 
cells. Another example is hyaluronan, 
which in vivo is restricted to the narrow 
spaces between keratinocytes and is pre-
vented from diffusing beyond the basal 
lamina and the water barrier in stratum 
corneum, but it is free to escape into a 
vast volume of medium in monolayer 
cultures. To mimic conditions that keep 
hyaluronan in its normal domain and 
concentration, and to provide HB-EGF 
diffusion routes and spaces similar to 
those in vivo, Monslow et al. (2009, this 
issue) used a culture system based on a 
unique epidermal cell line (REK) that can 
form an “epidermis” structurally and func-
tionally resembling its “real” counterpart 
(Tammi et al., 2000). REK-organotypic 
cultures do not need dermal fibroblasts 
to differentiate fully, thus avoiding the 
complex interplay between the different 
cell types in other organotypic or explant 
skin organ culture models. The paper by 
Monslow et al. demonstrates the useful-
ness of these REK-organotypic cultures in 
wound-healing research.
Hyaluronan is involved  
in tissue remodeling
Haluronan (or hyaluronic acid or 
hyaluronate) is abundant in embryonic 
tissues, reaching peak concentrations 
in each organ before maturation, when 
cells proliferate and migrate to their 
final positions (Toole, 2004). The same 
pattern of transient hyaluronan accu-
mulation is seen whenever adult tissues 
undergo rapid remodeling, whether as 
a result of injury, inflammation, or can-
cer. Hyaluronan is deposited around 
inflamed joints in rheumatoid arthritis, 
causing morning stiffness, and it pro-
motes tumor growth and invasion when 
it accumulates on malignant cells or in 
the surrounding matrix. In each case, it 
forms a pliable, temporary matrix that 
enables cell proliferation or movement, 
and it amplifies growth factor signals 
important in the remodeling process. 
Transient accumulation of hyaluronan 
in granulation tissue, a model of dermal 
wound response, has been known for 
decades, and the prenatal abundance 
of hyaluronan has been suggested to 
play a role in scarless wound healing 
of fetal skin (Mack et al., 2003). Recent 
work shows that activation of hyaluro-
nan synthesis also occurs in wounded 
adult epidermis (Maytin et al., 2004; 
Tammi et al., 2005).
Hyaluronan in the epidermis
Hyaluronan fills the narrow spaces 
between human epidermal basal and 
spinous cells (Tammi et al., 1988). Its 
concentration in this space has been 
calculated to be as high as 2.5 mg/ml, 
comparable to its concentration in syn-
ovial fluid. Following trauma in vivo, the 
concentration of epidermal hyaluronan 
rapidly increases up to sevenfold (Tammi 
et al., 2005). This response requires only 
compromised epidermal barrier func-
tion, without direct impact on the der-
mis (Maytin et al., 2004; Tammi et al., 
2005). The hyaluronan response is not 
restricted to the area immediately adja-
cent to the wound, but spreads consid-
erably from wound margins, indicating 
the release of factors capable of activat-
ing hyaluronan synthesis (Figure 1 and 
Tammi et al., 2005).
In the basal state, the half-life of 
hyaluronan is only about one day in 
human skin organ cultures (Tammi et 
al., 1991) and even shorter in the orga-
notypic epidermis of rat keratinocytes 
(REK; Tammi et al., 2000). The bio-
logical relevance of this short turnover 
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time has been puzzling, but it becomes 
more understandable in light of the 
work of Monslow et al. (2009), which 
illustrates the extremely rapid upregula-
tion of epidermal hyaluronan synthesis 
following mechanical injury. The new 
data emphasize and corroborate ear-
lier in vivo work (Maytin et al., 2004; 
Tammi et al., 2005), stressing the urgent 
need to rebuild a disrupted epidermal 
barrier by keratinocytes. But how is the 
rapid hyaluronan surge involved in this 
process?
epidermal activation and 
re-epithelialization after wounding
Keratinocytes from the basal and 
spinous cell layers adjacent to a 
wound acquire an activated pheno-
type (Freedberg et al., 2001), in which 
proliferation is increased and differen-
tiation is retarded, forming a pool of 
migration-competent keratinocytes to 
rapidly cover the wound and re-estab-
lish the permeability barrier. Growth 
factor receptors and their ligands origi-
nating from epidermis (like HB-EGF), 
dermis (like keratinocyte growth factor 
(KGF)), and inflammatory cells have 
been shown to be important in epi-
dermal activation and wound healing 
(reviewed by Barrientos et al., 2008). 
The culture model used by Monslow et 
al. (2009) clarifies an important point 
in this process: Growth factor signals 
from epidermis alone (HB-EGF) suffice 
to stimulate widespread hyaluronan 
synthesis as a part of the wound heal-
ing response. Although KGF and other 
mediators from the dermal side contrib-
ute to and tune the healing response, 
these factors do not dominate (at least 
in the autocrine and paracrine process 
of keratinocyte hyaluronan synthesis).
An idea supported by the present 
work is that hyaluronan is an important 
contributor to re-epithelialization. Data 
are accumulating to support this idea, as 
described below. Factors that stimulate 
hyaluronan synthesis (e.g., EGF, KGF, 
and retinoic acid) also increase prolifera-
tion and epidermal thickness, whereas 
factors that decrease hyaluronan syn-
thesis (e.g., transforming growth factor-β 
and glucocorticoids) inhibit proliferation 
and promote differentiation (Karvinen 
et al., 2003; Pasonen-Seppänen et al., 
2003, 2008; Pienimäki et al., 2001; 
Ågren et al., 1995). Accordingly, 
when hyaluronan content is reduced 
by the hyaluronan synthesis inhibitor 
4-methylumbelliferone (Rilla et al., 2004), 
epidermal activation by EGF is blocked, 
and when hyaluronan is removed by 
hyaluronidase treatment (Passi et al., 
2004), epidermal differentiation is 
enhanced. These findings suggest that an 
increase in epidermal hyaluronan con-
tent supports keratinocyte proliferation 
and puts the brakes on terminal differen-
tiation, providing maximum numbers of 
activated keratinocytes for resurfacing an 
open wound. Hyaluronan bulging in the 
intercellular spaces reduces cohesion 
between keratinocytes, making room for 
cell movement and inducing cytoplasmic 
signals such as Rac1, which enhance cell 
migration (Bakkers et al., 2004) and the 
formation of filopodia/microvilli (Kultti et 
al., 2006; Rilla et al., 2008).
Future lines of research  
and unanswered questions
The literature supports the hypothesis 
that stimulation by hyaluronan sup-
ports a migratory and proliferative 
phenotype of epidermal keratinocytes. 
However, it has not been clearly 
determined whether the hyaluronan 
must be synthesized by the keratino-
cytes themselves or whether hyaluro-
nan provided exogenously could serve 
the same purpose. More direct data on 
hyaluronan in epidermal physiology 
might arise from experiments in which 
epidermal hyaluronan synthesis is 
completely inhibited. Currently, dele-
tion of the has2 gene, the isoenzyme 
of the hyaluronan synthase (has) fam-
ily with the highest synthetic capacity, 
causes embryonal lethality, whereas 
has1 and has3 knockouts have no 
phenotype (Camenisch et al., 2000). 
Indeed, future studies are needed to 
specifically target has2 expression in 
epidermis.
Related to the importance of Has 
expression in wound healing is the role 
of cell surface receptors such as CD44 
and TLR2 (Jiang et al., 2007), which 
have been reported to inform cells 
about the size and content of hyaluro-
nan at the cell surface and to mediate 
the effects of hyaluronan. However, 
the addition of exogenous hyaluronan 
often does not recapitulate the effects 
of endogenous hyaluronan synthesis, 
and CD44 knockout mice have very 
minor skin problems, indicating that 
cell surface receptors cause only a part 
of the response.
Interesting new questions about has 
expression and function have arisen 
from this study. One relates to the rapid 
increase in hyaluronan synthesis fol-
lowing injury. Although has2 belongs 
to the primary target genes of EGFR 
signaling (Saavalainen et al., 2005) 
Figure 1. Spreading of the hyaluronan response in injured epidermis. Mouse tail skin was processed 
for histology 3 days after wounding by tape stripping and stained using a biotinylated hyaluronan 
binding probe as previously described (Tammi et al., 2005). The brown color indicates the localization of 
hyaluronan. The images were taken laterally from the wound edge (indicated by the arrow). Hyaluronan 
staining in the epidermis close to the wound (white asterisk) is stronger than the more lateral signal; 
however, the increased hyaluronan reaction is still clearly visible 1 mm from the edge (black asterisks) 
compared with the rather faint staining closer to the right side of the image.
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and has gene expression is rapidly 
upregulated by HB-EGF, augmented 
hyaluronan production appears too 
rapidly (15 min) to be accounted for 
by transcriptional upregulation. Does 
existing Has protein on plasma mem-
brane become activated, for instance, 
by phosphorylation (Goentzel et al., 
2006), or are Has proteins transferred 
from their ER/Golgi stores to the plasma 
membrane, the only cellular site where 
Has appears to be enzymatically active 
(Rilla et al., 2005)?
can epidermal hyaluronan become  
a therapeutic target?
It can be envisioned that diseases asso-
ciated with excessive epidermal activa-
tion might benefit from suppression of 
hyaluronan synthesis, for instance, by 
local application of currently known 
(Jokela et al., 2008; Rilla et al., 2004) 
or new inhibitors. On the other hand, 
opposite clinical indications might 
arise for treating atrophic epidermis or 
enhancing wound healing responses. 
Hyaluronan is already being applied 
to wounds, dressings, and cosmetic 
preparations alone or in combination 
with skin cells or growth factors (Price 
et al., 2007), even though the molecu-
lar mechanisms of its effects remain 
obscure. Future treatment options 
depend on whether exogenously 
applied hyaluronan is found to retain 
the qualities associated with endog-
enously synthesized hyaluronan.
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